See more : Shenzhen Prince New Materials Co., Ltd. (002735.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Odonate Therapeutics, Inc. (ODT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Odonate Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Max Healthcare Institute Limited (MAXHEALTH.BO) Income Statement Analysis – Financial Results
- Paramount Group, Inc. (PGRE) Income Statement Analysis – Financial Results
- Dancomech Holdings Berhad (5276.KL) Income Statement Analysis – Financial Results
- Deutsche EuroShop AG (DEQ.DE) Income Statement Analysis – Financial Results
- XANO Industri AB (publ) (XANO-B.ST) Income Statement Analysis – Financial Results
Odonate Therapeutics, Inc. (ODT)
About Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 117.04M | 104.03M | 79.95M | 27.90M | 2.62M | 0.00 |
| General & Administrative | 10.39M | 10.90M | 10.82M | 4.84M | 463.00K | 158.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.39M | 10.90M | 10.82M | 4.84M | 463.00K | 158.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -316.00K |
| Operating Expenses | 127.43M | 114.93M | 90.76M | 32.74M | 3.09M | -158.00K |
| Cost & Expenses | 127.43M | 114.93M | 90.76M | 32.74M | 3.09M | 158.00K |
| Interest Income | 0.00 | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 445.00K | 381.00K | 350.00K | 20.00K | 22.82K | 0.00 |
| EBITDA | -125.91M | -111.44M | -88.61M | -32.72M | -3.09M | -158.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -127.43M | -114.93M | -90.76M | -32.74M | -3.09M | -158.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.08M | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -126.35M | -111.83M | -88.96M | -32.74M | -3.09M | -158.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.08M | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
| Net Income | -126.35M | -111.83M | -88.96M | -32.74M | -3.09M | -158.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.01 |
| EPS Diluted | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.01 |
| Weighted Avg Shares Out | 32.82M | 27.63M | 24.46M | 14.17M | 26.89M | 26.89M |
| Weighted Avg Shares Out (Dil) | 32.82M | 27.63M | 24.46M | 14.17M | 26.89M | 26.89M |
Franklin Resources Inc. Has $38.61 Million Stock Position in Odonate Therapeutics Inc (NASDAQ:ODT)
Franklin Resources Inc. lowered its stake in shares of Odonate Therapeutics Inc (NASDAQ:ODT) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,189,958 shares of...
Telepizza y Burger King cierran sus restaurantes mientras refuerzan el servicio de envío a domicilio
Cadenas de restauración como Telepizza o Burger King han decidido cerrar sus tiendas físicas al público por toda España y centrar su actividad en el envío de comida a domicilio por la propagación del coronavirus. Así lo han informado Telepizza...
Telepizza cierra sus tiendas propias y solo realizará entregas sin contacto
Los clientes abonarán el importe de la compra mediante tarjeta bancaria en la web o en la 'app' y recibirán el producto en sus casas sin contacto con el repartidor.
Fmr LLC Sells 109,900 Shares of Odonate Therapeutics Inc (NASDAQ:ODT)
Fmr LLC decreased its stake in Odonate Therapeutics Inc (NASDAQ:ODT) by 41.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 154,616 shares of the...
Odonate Therapeutics (NASDAQ:ODT) Stock Rating Upgraded by ValuEngine
Odonate Therapeutics (NASDAQ:ODT) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued to investors on Monday, ValuEngine reports. Other equities analysts also recently issued research reports about the stock....
Brokerages Expect Odonate Therapeutics Inc (NASDAQ:ODT) Will Announce Earnings of -$1.02 Per Share
Wall Street analysts expect that Odonate Therapeutics Inc (NASDAQ:ODT) will report ($1.02) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Odonate Therapeutics’ earnings. Odonate Therapeutics posted earnings per share of ($1.16)...
Odonate Therapeutics Inc (NASDAQ:ODT) Given Average Recommendation of "Hold" by Analysts
Shares of Odonate Therapeutics Inc (NASDAQ:ODT) have received an average recommendation of “Hold” from the five analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, one has assigned...
Telepizza se alía con Glovo para ofrecer sus productos en esta plataforma, pero con sus propios repartidores
Telepizza, una de las principales cadenas de restauración organizada de España, se ha aliado con Glovo para ofrecer sus productos a través de esta plataforma, aunque con la salvedad de que la entrega la seguirán haciendo sus propios repartidores. Una...
Odonate Therapeutics (NASDAQ:ODT) Upgraded to "Buy" at Zacks Investment Research
Odonate Therapeutics (NASDAQ:ODT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday, Zacks.com reports. The brokerage currently has a $36.00 target price on the stock. Zacks Investment Research‘s...
Odonate Therapeutics Inc (NASDAQ:ODT) Position Lowered by California Public Employees Retirement System
California Public Employees Retirement System decreased its stake in shares of Odonate Therapeutics Inc (NASDAQ:ODT) by 20.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 62,156 shares of the company’s...
Source: https://incomestatements.info
Category: Stock Reports